A 70-year-old man with an Eastern Cooperative Oncology Group performance status of 0 and a medical history significant for hypertension and hypercholesterolemia initially presented with an elevated pre-treatment prostate-specific antigen (PSA) level of 4.95 ng/mL. The gene discussed is KLK3; the disease is Hypertension.